These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3344936)

  • 1. Diagnosis and immunotherapy of mould allergy. VII. IgG subclass response and relation to the clinical efficacy of immunotherapy with Cladosporium.
    Malling HJ; Djurup R
    Allergy; 1988 Jan; 43(1):60-70. PubMed ID: 3344936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and immunotherapy of mould allergy. VI. IgE-mediated parameters during a one-year placebo-controlled study of immunotherapy with Cladosporium.
    Malling HJ; Dreborg S; Weeke B
    Allergy; 1987 May; 42(4):305-14. PubMed ID: 3303997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and immunotherapy of mould allergy. VIII. Qualitative and quantitative estimation of IgE in Cladosporium immunotherapy.
    Malling HJ; Stahl Skov P
    Allergy; 1988 Apr; 43(3):228-38. PubMed ID: 2454038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and immunotherapy of mould allergy. V. Clinical efficacy and side effects of immunotherapy with Cladosporium herbarum.
    Malling HJ; Dreborg S; Weeke B
    Allergy; 1986 Sep; 41(7):507-19. PubMed ID: 3789332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind, multicenter immunotherapy trial in children, using a purified and standardized Cladosporium herbarum preparation. I. Clinical results.
    Dreborg S; Agrell B; Foucard T; Kjellman NI; Koivikko A; Nilsson S
    Allergy; 1986 Feb; 41(2):131-40. PubMed ID: 3518526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and immunotherapy of mould allergy. With special reference to Cladosporium herbarum.
    Malling HJ
    Dan Med Bull; 1990 Feb; 37(1):12-22. PubMed ID: 2178885
    [No Abstract]   [Full Text] [Related]  

  • 7. IgG subclass antibody markers in grass pollen immunotherapy.
    Moss RB
    N Engl Reg Allergy Proc; 1987; 8(6):409-15. PubMed ID: 3325818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG subclass antibody response in grass pollen-allergic patients undergoing specific immunotherapy. Prognostic value of serum IgG subclass antibody levels early in immunotherapy.
    Djurup R; Osterballe O
    Allergy; 1984 Aug; 39(6):433-41. PubMed ID: 6496881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind, multicenter immunotherapy trial in children, using a purified and standardized Cladosporium herbarum preparation. II. In vitro results.
    Karlsson R; Agrell B; Dreborg S; Foucard T; Kjellman NI; Koivikko A; Einarsson R
    Allergy; 1986 Feb; 41(2):141-50. PubMed ID: 3518527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and immunotherapy of mould allergy. IV. Relation between asthma symptoms, spore counts and diagnostic tests.
    Malling HJ
    Allergy; 1986 Jul; 41(5):342-50. PubMed ID: 2429577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The subclass nature and clinical significance of the IgG antibody response in patients undergoing allergen-specific immunotherapy.
    Djurup R
    Allergy; 1985 Oct; 40(7):469-86. PubMed ID: 3907393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The IgE and IgG subclass antibody response in patients allergic to yellow jacket venom undergoing different regimens of venom immunotherapy.
    Djurup R; Malling HJ; Søndergaard I; Weeke B
    J Allergy Clin Immunol; 1985 Jul; 76(1):46-55. PubMed ID: 4008813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and immunotherapy of mould allergy. III. Diagnosis of Cladosporium allergy by means of symptom score, bronchial provocation test, skin prick test, RAST, CRIE and histamine release.
    Malling HJ; Dreborg S; Weeke B
    Allergy; 1986 Jan; 41(1):57-67. PubMed ID: 2421599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A placebo-controlled trial of immunotherapy with two extracts of Dermatophagoides pteronyssinus in allergic rhinitis, comparing clinical outcome with changes in antigen-specific IgE, IgG, and IgG subclasses.
    McHugh SM; Lavelle B; Kemeny DM; Patel S; Ewan PW
    J Allergy Clin Immunol; 1990 Oct; 86(4 Pt 1):521-31. PubMed ID: 1699985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of a common regulation of IgE and IgG-subclass antibodies in humans during immunotherapy.
    Søndergaard I; Poulsen LK; Osterballe O; Weeke B
    Allergy; 1992 Oct; 47(5):467-70. PubMed ID: 1485649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring allergen immunotherapy of pollen-allergic patients: the ratio of allergen-specific IgG4 to IgG1 correlates with clinical outcome.
    Gehlhar K; Schlaak M; Becker W; Bufe A
    Clin Exp Allergy; 1999 Apr; 29(4):497-506. PubMed ID: 10202364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The change of allergen-specific IgG subclass antibodies during immunotherapy in mite-sensitive asthmatic children.
    Wang JY; Lei HY; Hsieh KH
    Asian Pac J Allergy Immunol; 1992 Jun; 10(1):11-8. PubMed ID: 1418178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgG4 but no IgG1 antibody production after intralymphatic immunotherapy with recombinant MAT-Feld1 in human.
    Freiberger SN; Zehnder M; Gafvelin G; Grönlund H; Kündig TM; Johansen P
    Allergy; 2016 Sep; 71(9):1366-70. PubMed ID: 27253988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
    Rossi RE; Monasterolo G
    Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgG subclass antibodies in response to house dust mite immunotherapy.
    Nakagawa T
    N Engl Reg Allergy Proc; 1987; 8(6):423-8. PubMed ID: 3481430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.